Syringe, dental, anaesthesia Australija - anglų - Department of Health (Therapeutic Goods Administration)

syringe, dental, anaesthesia

specialites septodont pty ltd - 35969 - syringe, dental, anaesthesia - to be used in dentistry for administering local anaesthetic

R.T.R.+ 80/20 - Bone matrix implant, synthetic Australija - anglų - Department of Health (Therapeutic Goods Administration)

r.t.r.+ 80/20 - bone matrix implant, synthetic

specialites septodont pty ltd - 17751 - bone matrix implant, synthetic - this product is a microporous & microporous biphasic calcium phosphate ceramic consisting of 20% hydroxyapatite (ha) & 80% beta-tricalcium phosphate (?-tcp). presented in a porous form required for the biological exchanges particularly for bone ingrowth. may be used with physiological saline, patient?s own serum, whole blood, or bone marrow aspirate (bma). the synthetic bone substitute is progressively replaced by new bone according to the remodelling process. the synthetic bone substitute is intended for use to reconstruct bony voids or bone gaps in particular in maxillofacial applications: - periodontal/intrabony defects filling - ridge augmentation - implant preparation, placement in extraction sites - sinus lifts - cystic cavities filling the performances of the synthetic bone substitute are the filling of bone defects and the bony ingrowth from local osseous tissue onto the surface of the product (osteoconduction process). the total resorption of the product depends on numerous factors such as its size and volume, the location of the defect, the surgical technique, the health status of the patient. the bone reconstruction time is always inferior to the total resorption time.

R.T.R.+ 40/60 - Bone matrix implant, synthetic Australija - anglų - Department of Health (Therapeutic Goods Administration)

r.t.r.+ 40/60 - bone matrix implant, synthetic

specialites septodont pty ltd - 17751 - bone matrix implant, synthetic - this product is a microporous & microporous biphasic calcium phosphate ceramic consisting of 60% hydroxyapatite (ha) & 40% beta-tricalcium phosphate (?-tcp). presented in a porous form required for the biological exchanges particularly for bone ingrowth. may be used with physiological saline, patient?s own serum, whole blood, or bone marrow aspirate (bma). the synthetic bone substitute is progressively replaced by new bone according to the remodelling process. the synthetic bone substitute is intended for use to reconstruct bony voids or bone gaps in particular in maxillofacial applications: - periodontal/intrabony defects filling - ridge augmentation - implant preparation, placement in extraction sites - sinus lifts - cystic cavities filling the performances of the synthetic bone substitute are the filling of bone defects and the bony ingrowth from local osseous tissue onto the surface of the product (osteoconduction process). the total resorption of the product depends on numerous factors such as its size and volume, the location of the defect, the surgical technique, the health status of the patient. the bone reconstruction time is always inferior to the total resorption time.

Cresophene Australija - anglų - Department of Health (Therapeutic Goods Administration)

cresophene

specialites septodont pty ltd - dexamethasone,parachlorophenol,thymol -

Racestyptine Solution bottle Australija - anglų - Department of Health (Therapeutic Goods Administration)

racestyptine solution bottle

specialites septodont pty ltd - aluminium chloride, quantity: 250 mg/ml - solution - excipient ingredients: oxyquinoline sulfate; ethanol; purified water - - gingival exudation and gingival haemorrhages, - apical haemorrhages, - gingival retraction (by in situ impregnation of a cord).